Get started
Author

João Moreira-Pinto

Observed names: J. Moreira Pinto, J. Moreira-Pinto, J. Pinto, João M Pinto, João Moreira Pinto, João Pinto
ORCID: 0000-0002-8981-3272
Observed ORCID: 0000-0002-8981-3272
OpenAlex ID: A5068575845
Loss of HER2 and disease prognosis after neoadjuvant treatment of HER2+ breast cancer.
2019 · Francisco P Branco, Duarte Machado, et al. · PubMed Central · 39
ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer—A Retrospective Analysis
2019 · João Godinho, Mafalda Casa-Nova, et al. · The Oncologist · 28
Febrile Neutropenia in Patients with Solid Tumors Undergoing Intravenous Chemotherapy
2020 · João Moreira-Pinto, Inês Leão, et al. · Oncology Research and Treatment · 15
Loss of RAS Mutations in Liquid Biopsies of Patients With Multi-Treated Metastatic Colorectal Cancer
2023 · Joana Albuquerque, Diana Neto da Silva, et al. · The Oncologist · 4
PDF
Loss of HER2 amplification and disease prognosis after neoadjuvant treatment of HER2 amplified breast cancer
2018 · F. Paralta Branco, F. Silva, et al. · European Journal of Cancer · 3
Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice
2024 · Alina Rosinha, Carlos Rabaça, et al. · Frontiers in Oncology · 2
PDF
Fatal Clostridium septicum febrile neutropenia during adjuvant chemotherapy for early breast cancer
2020 · João Moreira-Pinto, José Luís Passos-Coelho, et al. · BMJ Case Reports · 2
Retrospective multicenter cohort of nab-paclitaxel plus gemcitabine (NG) after FOLFIRINOX failure in advanced pancreatic cancer (APC): Effectiveness, tolerability, and response markers.
2017 · Ines Vendrell, Arlindo Rebelo Ferreira, et al. · Journal of Clinical Oncology · 2
229P Portuguese real-world use of atezolizumab–bevacizumab and durvalumab–tremelimumab in advanced hepatocellular carcinoma
2026 · M.M.V. Machete, B.M. Silva, et al. · Annals of Oncology
PDF
Risk of relapse and patient selection for metastatic colorectal cancer liver surgery.
2024 · Madalena Machete, Pedro Azevedo, et al. · Journal of Clinical Oncology
PDF
2209P Mutational status of non-small cell lung cancer in Portugal: A multicentric study
2023 · J.A. Duarte, D.N. Silva, et al. · Annals of Oncology
PDF
Association between prostate-specific antigen decline and survival outcomes in patients with metastatic castrate-resistant prostate cancer treated with first line abiraterone acetate
2022 · L. Leal da Costa, J. Albuquerque, et al. · European Urology Open Science
P-171 Prognostic value of conversion from RAS-mutated to RAS wild-type during treatment of metastatic colorectal cancer using liquid biopsies – real-world data of two Portuguese institutions
2022 · J. Albuquerque, D. Neto da Silva, et al. · Annals of Oncology
410P Extent of lymph node (LN) resection and tumour sidedness in operable colon cancer (CC) stage and survival
2020 · P. Simões, A. Faria, et al. · Annals of Oncology
An Unusual Small Bowel Lesion
2020 · Maria Pia Costa-Santos, João Moreira-Pinto, et al. · GE Portuguese Journal of Gastroenterology
Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer and its impact on surgical morbidity: Real life experience
2019 · L. Jeronimo Alves, J. Ascensão, et al. · European Urology Supplements
Outcomes of pancreatic adenocarcinoma resection between initial resectable and borderline/unresectable patients undergoing neoadjuvant chemotherapy: a two-center study
2019 · J. Moreira-Pinto, J. Godinho, et al. · Annals of Oncology
PDF
Molecular profile of ampulla of vater carcinoma (AVC): A rare tumor type with meaningful molecular alterations.
2019 · João Pinto, Helena Verdaguer, et al. · Journal of Clinical Oncology
Febrile Neutropenia: a systematic review of the first 5 years of a cancer unit
2017 · J. Pinto, I. Leão, et al. · Annals of Oncology
PDF
Works count: 19
Citation count: 95
H-index: 4
I10-index: 3
Year
Topic
Type